Tiragolumab and Atezolizumab in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC) and Untreated Brain Metastases
Clinical trial NCT05746481 · TERMINATED
Trial details
- NCT number
- NCT05746481
- Sponsor
- Liza Villaruz, MD
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-10
- Primary completion
- 2024-08-19
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.